UNITED STATES ~~SECURITIES AND EXCHANGE COMMISSION~~

~~Washington,~~SECURITIES AND DCEXCHANGE ~~20549~~COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT ~~Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934~~

~~Date~~Pursuant to ofSection 13 ~~Report~~ OR 15(~~Date~~d) of ~~earliest~~The ~~event~~Securities ~~reported):~~Exchange ~~January 2,~~Act ~~2008~~of ~~(January 1, 2008)~~1934

~~AMERICAN~~Date of ~~MEDICAL~~Report ~~TECHNOLOGIES~~(Date of earliest event reported): February 17, ~~INC.~~2009

~~(Exact name of~~American ~~Registrant~~Medical ~~as specified in charter)~~Technologies, Inc.

Delaware		0-19195		38-2905258
(State or othis jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

(Exact name of Registrant as specified in its charter)

Delaware		0-19195		38-2905258
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

5655 Bear Lane

Corpus Christi, TX 78405 ~~(Address of principal executive offices)~~

(Address of principal executive offices)

Registrant’s telephone number, including area code: (361) 289-1145

~~Check the appropriate box~~Not ~~below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).~~Applicable

~~o Written communications pursuant to Rule 425 under the Securities Act~~ (17Former name ~~CFR~~or ~~230.425)~~former oaddress, ~~Soliciting~~if ~~material~~changed ~~pursuant~~since tolast ~~Rule 14a-12 under the Exchange Act (17 CFR240.14a-12~~report) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)). o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13(e)-4(c))

~~Forward~~Check ~~Looking~~the ~~Statements~~appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

~~This~~o ~~Form 8-K~~Written ~~and~~communications ~~other~~pursuant ~~reports filed by Registrant from time~~ to ~~time~~Rule ~~with~~425 under the Securities ~~and~~Act ~~Exchange Commission~~ (~~collectively~~17 ~~the “Filings”)~~CFR contain or may contain forward looking statements and information that are based upon beliefs of, and information currently available to, Registrant’s management as well as estimates and assumptions made by Registrant’s management230. When used in the filings the words “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan” or the negative of these terms and similar expressions as they relate to Registrant or Registrant’s management identify forward looking statements. Such statements reflect the current view of Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors (including the risks contained in the section of the Registrant’s Form 10-K entitled “Risk Factors”425) relating to Registrant’s industry, Registrant’s operations and results of operations and any businesses that may be acquired by Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

~~Although~~o ~~the~~Soliciting ~~Registrant~~material ~~believes~~pursuant that the expectations reflected in the forward looking statements are reasonable, the Registrant cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, the Registrant does not intend to ~~update~~Rule ~~any~~14a-12 ofunder the ~~forward-looking~~ ~~statements~~Exchange toAct ~~conform~~(17 ~~these~~CFR ~~statements to actual results~~240.14a-12)

~~Item~~o ~~7.01~~Pre-commencement ~~Regulation~~communications FDpursuant ~~Disclosure~~to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Ono ~~January 1,~~Pre-commencement ~~2008,~~communications ~~Judd~~pursuant ~~Hoffman, President and Chief Executive Officer of the Registrant sent an email~~ to ~~the~~Rule ~~Registrant’s~~13e-4(c) ~~shareholders in~~under ~~which Mr. Hoffman provided a discussion of recent events related to~~ the ~~sale~~ ofExchange ~~Registrant’s~~Act ~~securities~~(17 byCFR ~~one of its shareholders~~240. ~~The email is furnished herein as Exhibit 99.1.~~13e-4(c))

~~The information in this Current Report, including the presentation attached hereto as Exhibit~~ITEM 995.~~1, is being furnished pursuant to Item 7~~02.~~01 and shall not be deemed “filed” for the purposes of Section 18~~ ofDEPARTURE ~~the~~OF ~~Securities~~DIRECTORS ~~and~~OR ~~Exchange~~PRINCIPAL ~~Act~~OFFICERS; ofELECTION ~~1934,~~OF asDIRECTORS; ~~amended, or otherwise subject to~~APPOINTMENT ~~the~~OF ~~liabilities~~PRINCIPAL ofOFFICERS; ~~that~~COMPENSATORY ~~Section.~~ARRANGEMENTS ~~The~~OF ~~information in the Current Report shall~~CERTAIN ~~not be incorporated by reference into any registration statement pursuant to the Securities Act of 1933, as amended~~OFFICERS.

~~Item~~Change in ~~9.01~~President/Chief ~~Financial~~Executive ~~Statements and Exhibits~~Officer

Judd D. Hoffman, the Chief Executive Officer and President of American Medical Technologies, Inc. (dthe “Company”), ~~Exhibits~~has resigned from those positions effective on February 17, 2009. Mr. Hoffman will remain as a director and Chairman of the Board of Directors of the Company.

~~99.1~~The ~~January~~Board of 1Directors appointed Jeffrey Goodman to serve as the Chief Executive Officer and President of the Company effective February 23, ~~2008~~2009, ~~email~~to ~~from~~fill the vacancy left by Mr. Hoffman’s departure. Jeffrey Goodman, age 53, founded Corestrength, Inc., a management consulting company, in 2003 and has served as the Chief Executive Officer of Corestrength, Inc. since August 2003. Form October 2000 to ~~shareholders~~June 2003, Mr. Goodman served as President of Dent-X in Elmsford, New York. From March 2998 to August 2000, Mr. Goodman served as Chief Executive Officer and President of Dexpo.com in Pennsylvania. Mr. Goodman has broad experience in dental manufacturing and distribution, having also served as the ~~Registrant~~President of ESPE America, and the Director of Marketing of Benco Dental. In addition to his experience in the dental industry, Jeffrey founded, developed and sold Business Technology Group, a distribution-oriented software developer. He received a B.A. in Accounting and Economics from Muhlenberg College in 1977, and an MBA in Finance from Northeastern University in 1981.

~~SIGNATURES~~Mr. Goodman has been appointed to the Board of Directors of the Company effective February 23, 2009.

~~Pursuant~~The Company entered into a consulting agreement with Corestrength, Inc., a Florida Corporation which agreed to provide the ~~requirements~~ services of ~~the~~Jeffrey Goodman. The ~~Securities~~Company ~~Exchange~~has ~~Act~~retained Mr. Goodman as Chief Executive Officer and as a director. The consulting agreement will commence on February 23, 2009 with an initial period ending May 31, 2009. After the conclusion of ~~1934~~the initial period, the ~~Registrant~~Company has ~~duly~~the right to renew the ~~caused~~contract ~~this~~for ~~report~~an additional three month term. In the event the contract is not extended for an additional three month term, and/or after such extension, the contract will automatically renew for additional monthly periods, unless either party provides ten (10) days written notice of their intention to terminate bethe ~~signed~~agreement. In onconsideration ~~its~~for ~~behalf~~Mr. byGoodman’s service to the ~~undersigned~~Company, ~~hereunto~~the ~~duly~~Company will pay a monthly fee of $12,000 to Corestrength, ~~authorized~~Inc. of which Mr. Goodman is a beneficial owner.

	AMERICAN MEDICAL TECHNOLOGIES, INC.
	By:	/s/ Judd Hoffman
		Judd Hoffman,
		Chief Executive Officer and President
		Dated: January 2, 2008

Corestrength, Inc. provides domestic and Canadian sales representation services for Spectrum Dental products, which the Company has an exclusive worldwide license to distribute and receives $3,000 per month plus 13.5% of any Spectrum sales in consideration for such sales representation services.

2ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

Exhibit Description of Exhibit

10.1*

Consulting Agreement between American Medical Technologies, Inc. and Corestrength, Inc.

* Filed herewith.

-2-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AMERICAN MEDICAL TECHNOLOGIES, INC.

February 19, 2009	By:	/s/ Judd D. Hoffman
		Judd D. Hoffman
		Chairman of the Board of Directors

-3-

Filing Compare · AMERICAN MEDICAL TECHNOLOGIES INC/DE